Piros L, Máthé Zs, Földes K, Langer R M
Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary.
Transplant Proc. 2011 May;43(4):1303-5. doi: 10.1016/j.transproceed.2011.03.090.
The occurrence of postoperative incisional hernia is more frequent after simultaneous pancreas-kidney transplantation compared with other transplanted parenchymal organs. These complications are especially dangerous in this patient population, because they can compromise the survival of the transplanted organ.
We performed a retrospective review of a series of adult patients with incisional herniae after 23 consecutive simultaneous pancreas-kidney transplantations between January 2004 and June 2010 seeking to identify risk factors. All 23 patients had a body mass index (BMI) of <25. All surgeons used a similar technique, including a median incision with an intraperitoneal approach, and systemic venous and enteric drainage methods and a layered fascial closure. All combined pancreas-kidney transplant recipients received induction with thymoglobulin and maintenance therapy with sirolimus, reduced-dose cyclosporine and corticosteroids.
An incisional hernia repair was performed in 8/23 patients (34.8%). Four reoperations were required in this group (50%), due to hemoperitoneum (n=2), intra-abdominal abscess (n=1), and venous thrombosis (n=1). The mean elapsed time between transplantation and hernioplasty was 24.5 months (range, 8-51). There was no significant difference in age, gender, BMI, dialysis modality, or operative time among affected compared with the other members of the group.
Despite lack of obesity we observed a relatively higher rate of postoperative herniase, possibly owing to the side effects of a thymoglobulin-sirolimus combination.
与其他实质器官移植相比,胰肾联合移植术后切口疝的发生率更高。这些并发症在该患者群体中尤其危险,因为它们可能危及移植器官的存活。
我们对2004年1月至2010年6月期间连续23例胰肾联合移植术后发生切口疝的成年患者进行了回顾性研究,以确定危险因素。所有23例患者的体重指数(BMI)均<25。所有外科医生均采用类似技术,包括经腹腔正中切口、全身静脉和肠道引流方法以及分层筋膜缝合。所有胰肾联合移植受者均接受了胸腺球蛋白诱导治疗,并采用西罗莫司、小剂量环孢素和皮质类固醇进行维持治疗。
23例患者中有8例(34.8%)进行了切口疝修补术。该组中有4例(50%)需要再次手术,原因是腹腔内出血(n = 2)、腹腔内脓肿(n = 1)和静脉血栓形成(n = 1)。移植与疝修补术之间的平均间隔时间为24.5个月(范围为8 - 51个月)。与该组其他成员相比,受影响患者在年龄、性别、BMI、透析方式或手术时间方面无显著差异。
尽管患者不存在肥胖情况,但我们观察到术后疝的发生率相对较高,这可能归因于胸腺球蛋白 - 西罗莫司联合使用的副作用。